- Baseline characteristics.
| Factor | Empirical oseltamivir discontinuation | ||
|---|---|---|---|
| Appropriate (n=66) | Late (n=144) | Total (n=210) | |
| Percentage of diabetes diagnosis | 45.45% | 46.53% | 46.19% |
| Percentage of hypertension diagnosis | 51.52% | 54.86% | 53.81% |
| Percentage of chronic kidney diseases | 19.70% | 7.64% | 11.43% |
| Percentage of liver disease diagnosis | 6.06% | 7.69% | 7.18% |
| Percentage of pulmonary disease diagnosis | 34.85% | 29.86% | 31.43% |
| Percentage of cardiovascular diagnosis | 45.45% | 34.72% | 38.10% |
| Percentage of cancer diagnosis | 10.61% | 8.33% | 9.05% |
| Average baseline creatinine clearance | 65.08 | 72.87 | 70.41 |
| Average length of stay | 11.44 | 11.59 | 11.54 |